Early Complications After Axillary and Inguinal Lymph Node Dissection in Stage III Melanoma Patients
NCT04680182 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104
Last updated 2022-09-02
Summary
This prospective randomized non-inferiority study is designed to compare the rate and severity of complications after axillary and inguinal lymph node dissection in stage III melanoma patients in a study group where the drain is left in place for three weeks and a control group consisting of patients managed according to the standard institutional protocol. Furthermore, variables associated with complications will be examined.
Conditions
- Melanoma
- Complication
Interventions
- PROCEDURE
-
Suction drain
Suction drain either kept for three weeks or gradually pulled out.
Sponsors & Collaborators
-
Oslo University Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-05-11
- Primary Completion
- 2021-04-06
- Completion
- 2022-09-01
Countries
- Norway
Study Locations
More Related Trials
-
Multicenter Selective Lymphadenectomy Trial (MSLT)
NCT00275496 ·Status: COMPLETED ·Phase: PHASE3
-
One-year Recurrence-free Survival of Melanoma Patients Eligible for a Sentinel Lymph Node Biopsy
NCT06809491 ·Status: ACTIVE_NOT_RECRUITING
-
Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer
NCT01526486 ·Status: COMPLETED ·Phase: NA
-
Minimally Invasive Groin Dissection for Melanoma
NCT01500304 ·Status: COMPLETED ·Phase: NA
-
High-resolution Magnetic Resonance Imaging (MRI) Scans to Look for Spread of Melanoma to Nearby Lymph Nodes
NCT00463892 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Groin Lymphadenectomy Extent For Metastatic Melanoma
NCT02166788 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of rIL-21 on Metastases in Lymph Nodes in Melanoma Skin Cancer
NCT00601861 ·Status: TERMINATED ·Phase: PHASE2
-
Neoadjuvant Combination Immunotherapy for Stage III Melanoma
NCT03842943 ·Status: RECRUITING ·Phase: PHASE2
-
Comparing SLNE With or Without Preoperative Hybrid SPECT/CT in Melanoma
NCT03683550 ·Status: UNKNOWN ·Phase: NA
-
A National Phase IV Study With Ipilimumab for Patients With Advanced Malignant Melanoma.
NCT02068196 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Safety of UV1 Vaccination in Combination With Ipilimumab in Patients With Unresectable or Metastatic Malignant Melanoma
NCT02275416 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase 1 Dose-finding Study of L19TNFα Plus Melphalan Using Isolated Inferior Limb Perfusion (ILP) in Subjects With Intransit Stage III/IV Melanoma
NCT01213732 ·Status: COMPLETED ·Phase: PHASE1
-
Isolated Limb Perfusion of Melphalan for Melanoma and Sarcoma Treatment
NCT01920516 ·Status: UNKNOWN
-
Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg
NCT00003789 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Risk Factors and Clinical Characterization of Rapidly Growing Melanoma
NCT02879474 ·Status: UNKNOWN
-
A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma
NCT00001296 ·Status: COMPLETED ·Phase: PHASE3
-
Intradermal Injection of Anti-CTLA-4 in Patients With Stage I/II Melanoma
NCT04274816 ·Status: COMPLETED ·Phase: PHASE1
-
Neoadjuvant L19IL2/L19TNF- Pivotal Study
NCT02938299 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma
NCT00006249 ·Status: UNKNOWN ·Phase: PHASE3
-
Identification and Characterization of Circulating Tumor Cells Before and After Treatment (Surgery and Radiotherapy) in a Cohort of Patients Treated for Resectable Stage I-III Merkel Cell Carcinoma
NCT06448611 ·Status: NOT_YET_RECRUITING
-
Isolated Limb Infusion Chemotherapy With Targeted Gene Therapy for Advanced, Unresectable Extremity Melanoma
NCT01531244 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Efficay and Safety of DAROMUN on Patient Treated by Intralesionnal Injection: DAROMEL
NCT07046728 ·Status: NOT_YET_RECRUITING
-
Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes
NCT01106040 ·Status: COMPLETED ·Phase: PHASE3
-
Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
NCT00297895 ·Status: COMPLETED ·Phase: NA
-
Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases
NCT04812470 ·Status: COMPLETED ·Phase: PHASE1